ESR1 and breast carcinoma: As an important biomarker in breast cancer, the ER is not only closely related to tumor‐related intracellular signaling activity but also related to tumor‐infiltrating immune cells such as macrophages, neutrophils, dendritic cells, natural killer cells, and B/T cells.32